Certara News

R1 RCM, Health Catalyst Downgraded as KeyBanc Reviews Health-tech Space

Seeking AlphaApr 10 12:56 ET

Certara Analyst Ratings

BenzingaApr 10 04:33 ET

Barclays Remains a Hold on Certara (CERT)

TipRanksApr 10 02:47 ET

Certara Analyst Ratings

BenzingaApr 4 04:52 ET

Certara Analyst Ratings

BenzingaMar 1 07:21 ET

Barclays Issues a Hold Rating on Certara (CERT)

TipRanksMar 1 02:55 ET

Leerink Partners Initiates Coverage On Certara With Market Perform Rating, Announces Price Target of $19

BenzingaFeb 26 08:36 ET

Certara Analyst Ratings

BenzingaFeb 26 08:35 ET

Certara Analyst Ratings

BenzingaJan 25 09:42 ET

UBS Initiates Coverage On Certara With Neutral Rating, Announces Price Target of $17

BenzingaDec 7, 2023 06:09 ET

Certara Analyst Ratings

BenzingaDec 7, 2023 06:08 ET

Certara Analyst Ratings

BenzingaDec 5, 2023 06:17 ET

BofA Securities Adjusts Price Target on Certara to $20 From $24, Maintains Buy Rating

MT NewswiresOct 20, 2023 10:40 ET

The Latest Analyst Ratings for Certara

BenzingaOct 11, 2023 11:00 ET

Stephens & Co. Reiterates Overweight on Certara, Maintains $20 Price Target

BenzingaOct 11, 2023 08:23 ET

Certara Analyst Ratings

BenzingaOct 11, 2023 08:22 ET

Robert W. Baird Reaffirms Their Hold Rating on Certara (CERT)

TipRanksSep 21, 2023 07:23 ET

Berenberg Bank Keeps Their Buy Rating on Certara (CERT)

TipRanksAug 28, 2023 15:05 ET

Certara Downgraded at Jefferies on Growth Headwinds

Seeking AlphaAug 22, 2023 12:07 ET

Certara Analyst Ratings

BenzingaAug 22, 2023 05:17 ET